Search research articles
Contact Us
Filters
Showing results (11-20 of 220) with videos related to
Page
of 22
Sort By:
Archives of Dermatology
|
May 1, 1991
Oncogenes. The growth control genes
S R Feldman, M Yaar
The British Journal of Dermatology
|
August 11, 2019
Rates of psoriasis in patients with palmoplantar pustulosis
W Haidari, S R Feldman
The British Journal of Dermatology
|
September 18, 2018
Biologics are too complicated to duplicate: should we be worried about biosimilars?
A Cline, S R Feldman
The British Journal of Dermatology
|
May 13, 2015
Oral tofacitinib for psoriasis: what happens with interrupted treatment?
H Alinia, S R Feldman
Oral Diseases
|
October 15, 2015
Ultraviolet phototherapy for cutaneous diseases: a concise review
R Vangipuram, S R Feldman
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 31, 2018
Manipulating mindsets to improve patient outcomes: is it ethical? Can it be avoided?
E Oussedik, S R Feldman
The British Journal of Dermatology
|
September 18, 2018
The perceived promise of p19 inhibitors
A Cline, S R Feldman
Clinical Therapeutics
|
November 24, 1999
Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians
A B Fleischer, S R Feldman
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2018
Heterogeneity and variation of innovator biologics
D R Sahni, S R Feldman
Journal of the American Academy of Dermatology
|
February 1, 1994
Polymerase chain reaction: basic concepts and clinical applications in dermatology
A C Lo, S R Feldman
Page
of 22
Search research articles
Search
Showing results (11-20 of 220) with videos related to
Sort By:
Page
of 22
Archives of Dermatology
|
May 1, 1991
Oncogenes. The growth control genes
S R Feldman, M Yaar
The British Journal of Dermatology
|
August 11, 2019
Rates of psoriasis in patients with palmoplantar pustulosis
W Haidari, S R Feldman
The British Journal of Dermatology
|
September 18, 2018
Biologics are too complicated to duplicate: should we be worried about biosimilars?
A Cline, S R Feldman
The British Journal of Dermatology
|
May 13, 2015
Oral tofacitinib for psoriasis: what happens with interrupted treatment?
H Alinia, S R Feldman
Oral Diseases
|
October 15, 2015
Ultraviolet phototherapy for cutaneous diseases: a concise review
R Vangipuram, S R Feldman
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 31, 2018
Manipulating mindsets to improve patient outcomes: is it ethical? Can it be avoided?
E Oussedik, S R Feldman
The British Journal of Dermatology
|
September 18, 2018
The perceived promise of p19 inhibitors
A Cline, S R Feldman
Clinical Therapeutics
|
November 24, 1999
Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians
A B Fleischer, S R Feldman
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 20, 2018
Heterogeneity and variation of innovator biologics
D R Sahni, S R Feldman
Journal of the American Academy of Dermatology
|
February 1, 1994
Polymerase chain reaction: basic concepts and clinical applications in dermatology
A C Lo, S R Feldman
Page
of 22